Sam Linsen

Founder of SquaredAnt, developing AI-enabled solutions at the interface of antibiotic resistance, biosensors, data transparency and digital diagnostics. • Built data-driven R&D platforms to analyse soil health and antibiotic resistance, integrating biosensor outputs with cloud-based dashboards and visual analytics. • Developed a proof-of-concept consumer toolkit for antibiotic residue testing in food, securing USD 80K in grants and winning the Tech China Award; obtained a China patent (CN111748459A). • Expa

Lead data management strategy and AI-driven evaluation work for a global non-profit shaping diagnostics policies and accelerating equitable access. • Direct AI performance assessments for TB CAD systems across regions and organisations, providing key evidence for the 2025 WHO policy statement on TB screening. Design reproducible data pipelines in R for clinical imaging datasets, enabling robust cross-country benchmarking of AI tools. • Deliver analyses that support reduced time-to-diagnosis for TB patien

Strategic advisor bridging Dutch deep-tech, life sciences, healthcare innovation and Chinese scientific ecosystems. • Guided Dutch organizations entering the China market through technology intelligence, sector analyses, and partnership structuring. • Coordinated minister-level missions and high-impact visits across life sciences, energy, space and automotive sectors (50+ participants). • Built a robust regional network of R&D leaders, government partners and industry executives, enabling long-term collabor

Led research on early-life malnutrition using zebrafish models to understand metabolic regulation under prenatal stress. • Secured competitive funding from EU, Chinese and Dutch agencies. • Published findings in high-impact open-access journals such as BMC Genomics and related venues; presented at international conferences.

Developed and implemented RNA-seq pipelines, optimized cloning methods and supported technology validation for industry partners.

This Certificate of Advanced Studies provided executive leadership training for technical entrepreneurs with a strong focus on branding, scaling, and strategy. It brought together ETH innovation excellence, world-class business professors, and an engaging venture funding ecosystem in the Zürich are

PhD in Molecular Biology at the Hubrecht Institute (Functional Genomics & Bioinformatics). Dissertation: “Small RNA Evolution and Distribution Patterns Based on Digital Gene Expression Profiling.” Core findings published in high-impact journals including Nature Methods, Genome Research, BMC Genomic

Thesis on the effect of Rad54 on double-strand break DNA repair at the Genetics Department, Erasmus Medical Centre. Contributed to research in a publication in the Journal of Cell Biology.

Research project that aimed to identify genetic markers that predict susceptibility to Multiple Systems Organ Failure.

Completed coursework in Oncology, Tumor Biology, and Immunology during this international exchange program.